United States
Germany
Japan
United Kingdom
China
Transient overexpression of NR2E3, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Proteins
Transient overexpression of NR3C2, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of RORA, transcript variant 4, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of THRB, transcript variant 2, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of THRB, transcript variant 3, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of ESRRB in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of NR3C1, transcript variant 6, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of MED1 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of ESR1, transcript variant 2, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of PGR, transcript variant 2, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of RARB, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of NR2E3, transcript variant 2, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of NR1I2, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of RORB in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of NR1D1 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
活动过滤器
优化搜索结果
Category
Target Symbol
- CONSTITUTIVE ANDROSTANE RECEPTOR (13)
- HNF 4 ALPHA (4)
- PPAR DELTA (4)
- PPAR GAMMA (4)
- RETINOIC ACID RECEPTOR ALPHA (4)
- GLUCOCORTICOID RECEPTOR (3)
- THYROID HORMONE RECEPTOR BETA (3)
- ANDROGEN RECEPTOR (2)
- ESTROGEN RECEPTOR 1 (2)
- ESTROGEN RECEPTOR BETA (2)
- ESTROGEN RELATED RECEPTOR BETA (2)
- ESTROGEN RELATED RECEPTOR GAMMA (2)
- NOR1 (2)
- NR2C1 (2)
- NR2E3 (2)
- NR2F2 (2)
- PPAR ALPHA (2)
- RETINOIC ACID RECEPTOR BETA (2)
- RETINOIC ACID RECEPTOR GAMMA (2)
- ROR ALPHA (2)
- VITAMIN D RECEPTOR (2)
- ARYL HYDROCARBON RECEPTOR (1)
- ASC1 (1)
- BILE ACID RECEPTOR (1)
- CHEMERIN (1)
- HNF4 GAMMA (1)
- LXR ALPHA (1)
- LXR BETA (1)
- MED1 (1)
- MINERALOCORTICOID RECEPTOR (1)
- NR0B1 (1)
- NR1D1 (1)
- NR1D2 (1)
- NR2C2 (1)
- NR2E1 (1)
- NR2F6 (1)
- NR5A2 (1)
- P23 (1)
- PGRMC1 (1)
- PGRMC2 (1)
- PLAAT4 (1)
- PROGESTERONE RECEPTOR (1)
- PXR (1)
- RETINOID X RECEPTOR ALPHA (1)
- RETINOID X RECEPTOR BETA (1)
- RETINOID X RECEPTOR GAMMA (1)
- ROR BETA (1)
- THYROID HORMONE RECEPTOR ALPHA (1)
Applications
Pathways
- Pathways in cancer (19)
- PPAR signaling pathway (14)
- Acute myeloid leukemia (8)
- Neuroactive ligand-receptor interaction (7)
- Thyroid cancer (7)
- Maturity onset diabetes of the young (6)
- Adipocytokine signaling pathway (5)
- Non-small cell lung cancer (5)
- Small cell lung cancer (5)
- Huntington's disease (4)
- Wnt signaling pathway (4)
- Oocyte meiosis (3)
- Prostate cancer (2)
- Circadian rhythm - mammal (1)
- Progesterone-mediated oocyte maturation (1)
